PerpEquitiesTop analysts on stock perps · Analyst
Eva Fortea Verdejo (Wells Fargo): analyst track record on stock perps
Eva Fortea Verdejo of Wells Fargo on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.9★
Success83%
Excess return+53.9%
rank#177
Ratings77
ratings on stock perps12
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 68 | 100 |
| Stock | 15 | 15 |
| Buy / hold / sell | 56 / 12 / 0 | 78 / 19 / 3 |
| Upgrades / downgrades / initiations | 3 / 1 / 4 | 4 / 1 / 11 |
| Price targets hit / missed | 31 / 37 (46%) | 54 / 46 (54%) |
| Avg. return after a rating (TipRanks) | +7.0% | +42.5% |
| Best / worst call | +190.5% / -63.6% | +372.3% / -63.6% |
After buy calls: median 21-day move +4.3% · vs S&P 500 +5.0% · targets hit within a year 100% (n = 11)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $RVMD Revolution Medicines, Inc. | Buy · Reiterated | $240 | +18.0% | Aug 27, 2026 |
Recent ratings
- Aug 27, 2026 $RVMD: Reiterated · Buy · $240 · article
- Aug 6, 2026 $RVMD: Reiterated · Buy · $240 · article
- Jun 1, 2026 $RVMD: Reiterated · Buy · $167 · article
- May 7, 2026 $RVMD: Maintained · Buy · $167 · article
- Apr 14, 2026 $RVMD: Maintained · Buy · $167 · article
- Apr 1, 2026 $RVMD: Maintained · Buy · $144 · article
- Feb 26, 2026 $RVMD: Maintained · Buy · $144 · article
- Jan 27, 2026 $RVMD: Reiterated · Buy · $100 · article
- Jan 8, 2026 $RVMD: Reiterated · Buy · $100 · article
- Dec 12, 2025 $RVMD: Reiterated · Buy · $100 · article
- Sep 11, 2025 $RVMD: Maintained · Buy · $70.00 · article
- Aug 15, 2025 $RVMD: Initiated · Buy · $67.00 · article
Eva Fortea Verdejo4.9★ · 83% success · +53.9% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.